机体素作为向人类和老鼠类固醇5α-减少酶1的抑制剂:结构-活性关系和对接分析
Shufang Qi1, Rong Cui1, Wanyu Li1
1Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Key Laboratory of Precision Anesthesiology of Zhejiang Province, Key Laboratory of Environment and Male Reproductive Medicine of Wenzhou, Wenzhou, Zhejiang 325027, China.
Chemico-biological interactions
|July 6, 2025
概括
包括三氨酸在内的有机素抑制了类固醇5α-减少酶1 (SRD5A1),这是对类固醇生成至关重要的酶. 这种干扰会影响二二的产生,对生殖和神经健康有潜在的影响.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 分子生物学分子生物学
背景情况:
- 类固醇5α-减少酶1 (SRD5A1) 对于将转化为二,影响大脑和生殖功能至关重要.
- 有机素是环境污染物,已知有毒作用,但它们与SRD5A1的特定相互作用尚未完全理解.
研究的目的:
- 系统地评估各种有机蛋白对人类和老鼠的抑制作用SRD5A1.1.
- 阐明在SRD5A1.1.上抑制有机素的作用机制和结构-活性关系.
主要方法:
- 对16种有机蛋白进行SRD5A1抑制活性查.
- 使用了酶抑制测定,分子对接和相关性分析.
- 抑制在体外和SF126细胞中进行了评估,以测量二二的产量.
主要成果:
- 双烯,三烯,三烯和三烯显著抑制了人类的SRD5A1,三烯显示最低的IC50 (4.38μM).
- 几种有机素也抑制了老鼠SRD5A1,表现出混合/非竞争性抑制和与NADPH结合部位的结合.
- 有机激素抑制涉及与氨酸残留物的相互作用,可能通过硫基结合,并减少细胞中的二二产量.
结论:
- 有机素是SRD5A1的强效抑制剂,其抑制作用与分子量,重原子和LogP相关.
- 这些发现揭示了有机素破坏类固醇生成和神经类固醇生物合成的潜力.
- 这项研究强调了由于有机素抑制SRD5A1对生殖和神经健康的影响.
关键词:
测试激素二氨酸 (Dihydrotestosterone) 是一种甲氨酸 (Methionine) 是一种含有甲的物质.有机蛋白质是有机蛋白质.类固醇5α-降解酶1 降解酶1 是一种类固醇.结构与活动的关系.更多相关视频
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:31Transducer Mechanism: Nuclear Receptors
1.7K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
01:25Drug-Receptor Bonds
3.3K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.3K
01:26Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
00:49Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K